Title : Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.

Pub. Date : 2017 Mar 3

PMID : 28256636






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice. Fenretinide fibroblast growth factor 21 Mus musculus
2 Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice. Fenretinide fibroblast growth factor 21 Mus musculus
3 Fenretinide normalised elevated levels of FGF21 in both high-fat diet-induced obese mice and in genetically obese-diabetic Leprdbmice. Fenretinide fibroblast growth factor 21 Mus musculus
4 Moreover, Fenretinide-mediated suppression of FGF21 was independent of body weight loss or improved hepatic insulin sensitivity and importantly does not induce unhealthy metabolic complications. Fenretinide fibroblast growth factor 21 Mus musculus
5 The repression of FGF21 levels by Fenretinide occurs by reduced binding of RARalpha and Pol-II at the Fgf21 promoter. Fenretinide fibroblast growth factor 21 Mus musculus
6 The repression of FGF21 levels by Fenretinide occurs by reduced binding of RARalpha and Pol-II at the Fgf21 promoter. Fenretinide fibroblast growth factor 21 Mus musculus
7 We therefore establish Fgf21 as a novel gene target of Fenretinide signalling via a retinoid-dependent mechanism. Fenretinide fibroblast growth factor 21 Mus musculus